RB1 and non-small cell lung carcinoma: DNA vaccine where E7 was altered to evade RB binding was more immunogenic compared to unaltered E7, further establishing the role of RB in immune response.35 Our single institution dataset indicates RB1 mutation to be associated with a lack of response to immunotherapy in NSCLC.